Jones

About Jones

Jones offers a doctor‑recommended nicotine replacement therapy in the form of slow‑release mints that help users manage cravings and satisfy oral fixation while quitting smoking or vaping. Customers receive a personalized quit plan and access to a supportive app community that provides behavioral tools, goal tracking, and peer encouragement. The company monetizes through direct sales of the nicotine lozenge kits and subscription options for ongoing access to the digital quit‑support platform.

```xml <problem> Quitting nicotine is challenging, with most individuals unable to quit cold turkey due to cravings and withdrawal symptoms. Traditional methods often lack personalized support and convenient access to FDA-approved nicotine replacement therapies. </problem> <solution> Jones provides a comprehensive, personalized nicotine replacement therapy (NRT) subscription service combined with behavioral support to improve quit rates. The platform delivers FDA-approved nicotine mints tailored to the user's dependency level, along with a mobile app that offers daily motivation, progress tracking, and community support. By addressing both the physical and psychological aspects of nicotine addiction, Jones aims to double users' chances of successfully quitting. </solution> <features> - Personalized quit plan based on individual nicotine dependency and goals - Subscription delivery of FDA-approved nicotine mints - Mobile app for habit formation, progress tracking, and community engagement - Daily text support with tips, tricks, and motivational messages - Doctor-recommended approach combining NRT with behavioral support - Community forum for peer support and shared experiences </features> <target_audience> The primary target audience includes individuals over 18 who are looking to reduce or eliminate their nicotine consumption, including smokers and vapers. </target_audience> <revenue_model> Jones operates on a subscription-based model, with recurring monthly fees for personalized NRT delivery and access to the mobile app and support services. </revenue_model> ```

What does Jones do?

Jones offers a doctor‑recommended nicotine replacement therapy in the form of slow‑release mints that help users manage cravings and satisfy oral fixation while quitting smoking or vaping. Customers receive a personalized quit plan and access to a supportive app community that provides behavioral tools, goal tracking, and peer encouragement. The company monetizes through direct sales of the nicotine lozenge kits and subscription options for ongoing access to the digital quit‑support platform.

Where is Jones located?

Jones is based in United States.

When was Jones founded?

Jones was founded in 2022.

How much funding has Jones raised?

Jones has raised $6.3M.

Location
United States
Founded
2022
Funding
$6.3M
Employees
49 employees
Investors
FoundryNextView Ventures

Jones

8
Relative Traction Score based on online presence metrics compared to companies in the same age group.

Executive Summary

Jones offers a doctor‑recommended nicotine replacement therapy in the form of slow‑release mints that help users manage cravings and satisfy oral fixation while quitting smoking or vaping. Customers receive a personalized quit plan and access to a supportive app community that provides behavioral tools, goal tracking, and peer encouragement. The company monetizes through direct sales of the nicotine lozenge kits and subscription options for ongoing access to the digital quit‑support platform.

quitwithjones.com300+
Founded 2022 – United States

Funding

No specific funding rounds found.

Total Funding

$6.3M

Backed by

FoundryNextView Ventures

Team (40+)

No team information available.

Company Description

Problem

Quitting nicotine is challenging, with most individuals unable to quit cold turkey due to cravings and withdrawal symptoms. Traditional methods often lack personalized support and convenient access to FDA-approved nicotine replacement therapies.

Solution

Jones provides a comprehensive, personalized nicotine replacement therapy (NRT) subscription service combined with behavioral support to improve quit rates. The platform delivers FDA-approved nicotine mints tailored to the user's dependency level, along with a mobile app that offers daily motivation, progress tracking, and community support. By addressing both the physical and psychological aspects of nicotine addiction, Jones aims to double users' chances of successfully quitting.

Features

Personalized quit plan based on individual nicotine dependency and goals

Subscription delivery of FDA-approved nicotine mints

Mobile app for habit formation, progress tracking, and community engagement

Daily text support with tips, tricks, and motivational messages

Doctor-recommended approach combining NRT with behavioral support

Community forum for peer support and shared experiences

Target Audience

The primary target audience includes individuals over 18 who are looking to reduce or eliminate their nicotine consumption, including smokers and vapers.

Revenue Model

Jones operates on a subscription-based model, with recurring monthly fees for personalized NRT delivery and access to the mobile app and support services.

Sources:

1
This profile is AI-generated from web data and may contain inaccuracies. Want to correct or remove an entry? Owners can claim edits via their company email domain, and signed-in users can submit sourced suggestions.